Cargando…
Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem Cells
Effective management of advanced cancer requires systemic treatment including small molecules that target unique features of aggressive tumor cells. At the same time, tumors are heterogeneous and current evidence suggests that a subpopulation of tumor cells, called tumor initiating or cancer stem ce...
Autores principales: | Taylor, William R., Fedorka, Sara R., Gad, Ibtissam, Shah, Ronit, Alqahtani, Hanan D., Koranne, Radhika, Kuganesan, Nishanth, Dlamini, Samkeliso, Rogers, Tim, Al-Hamashi, Ayad, Kholodovych, Veronika, Barudi, Yusuf, Junk, Damian, Rashid, Maisha S., Jackson, Mark W., Tillekeratne, L. M. Viranga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459861/ https://www.ncbi.nlm.nih.gov/pubmed/30976078 http://dx.doi.org/10.1038/s41598-019-42251-5 |
Ejemplares similares
-
Regulation of Ferroptosis by Transcription Factor E2F1 and RB
por: Kuganesan, Nishanth, et al.
Publicado: (2023) -
Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021) -
Multifunctional Nanomaterials for Ferroptotic Cancer Therapy
por: Shi, Zhiyuan, et al.
Publicado: (2022) -
Metabolism and iron signaling in ferroptotic cell death
por: Gao, Minghui, et al.
Publicado: (2015) -
DHODH tangoing with GPX4 on the ferroptotic stage
por: Wang, Fudi, et al.
Publicado: (2021)